Sterling Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $139K | Sell |
|
|||||
|
2025
Q2 | $133K | Buy |
|
|||||
|
2025
Q1 | $36.9K | Sell |
|
|||||
|
2024
Q4 | $220K | Sell |
|
|||||
|
2024
Q3 | $210K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $4.08M | Hold |
|
|||||
|
2018
Q2 | $3.26M | Hold |
|
|||||
|
2018
Q1 | $2.76M | Buy |
|
|||||
|
2017
Q4 | $1.26M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $300K | Buy |
|